Iwona Golonka | Pharmacology | Women Researcher Award

Posted on by ScienceFather

Dr. Iwona Golonka | Pharmacology | Best Researcher Award

Assistant Professor at Department of Physical Chemistry and Biophysics Pharmaceutical Faculty Wroclaw Medical University, Poland 

Dr. Iwona Golonka, an assistant professor at Wroclaw Medical University, is a distinguished researcher specializing in physical chemistry and pharmaceutical sciences. Over a career spanning more than two decades, she has made significant contributions to interdisciplinary research, blending theoretical chemistry with practical applications in drug development and antimicrobial therapies. She has authored 15 scientific papers with a cumulative impact factor of 48.378, including high-impact work published in top journals. Dr. Golonka’s innovative achievements include patents for novel pharmaceutical compositions, such as flotation tablets with enhanced drug delivery properties. She has collaborated with leading institutions in Poland and abroad, gaining expertise in techniques like DSC, HPLC, and chemometric methods. As a mentor and educator, she has guided numerous master’s theses and contributed to academic materials for pharmacy students. Recognized through prestigious awards and distinctions, Dr. Golonka exemplifies dedication to advancing science, education, and innovation in pharmaceutical research.

Professional Profile

Education

Dr. Iwona Golonka’s educational journey is rooted in a strong foundation in chemistry, beginning with her Master’s degree in Environmental Chemistry from the University of Wrocław in 1999. Her studies focused on understanding environmental systems through the lens of chemistry, setting the stage for her multidisciplinary approach to research. Following her Master’s, Dr. Golonka pursued full-time doctoral studies in inorganic chemistry at the same university, specializing in coordination chemistry within the Electron Paramagnetic Resonance (EPR) Group. She earned her Ph.D. in Chemical Sciences in 2006, where her research emphasized the intricate interactions of coordination compounds. Throughout her academic development, Dr. Golonka further honed her skills through research internships, such as a Socrates/Erasmus program at the University of Helsinki, where she investigated radical reaction kinetics in atmospheric conditions. Her diverse and rigorous educational background has enabled her to merge theoretical knowledge with practical applications, significantly contributing to pharmaceutical and physical chemistry.

Professional Experience

Dr. Iwona Golonka has been an assistant professor at Wroclaw Medical University since 2003, where she contributes to both research and education within the Faculty of Pharmacy’s Department of Physical Chemistry and Biophysics. Her professional experience spans various interdisciplinary research areas, with a particular focus on pharmaceutical sciences and biophysical techniques. Dr. Golonka has led and contributed to numerous collaborative research projects, exploring topics such as antimicrobial peptides, drug stability, and innovative drug delivery systems. She has developed expertise in analytical techniques like DSC, HPLC, and chemometric methods through research stays at institutions such as the Medical University of Gdańsk and Poznań University of Technology. Additionally, she has played a key role in mentoring students, guiding several master’s theses and contributing to the development of academic materials. Her involvement in numerous national and international collaborations highlights her ability to bridge theory and practice in cutting-edge pharmaceutical research.

Research Interests

Dr. Iwona Golonka’s research interests lie at the intersection of physical chemistry and pharmaceutical sciences. She focuses on understanding the molecular interactions and physicochemical properties of substances, particularly in the context of drug development and delivery. A key area of her research involves the stability and formulation of active pharmaceutical ingredients (APIs), where she employs advanced techniques such as Differential Scanning Calorimetry (DSC) and High-Performance Liquid Chromatography (HPLC). Dr. Golonka has a particular interest in antimicrobial peptides and their potential applications in treating conditions like acne vulgaris. She explores how these peptides interact with bacterial cellulose carriers to enhance their therapeutic effectiveness. Additionally, her research delves into the development of novel drug delivery systems, such as flotation tablets that provide prolonged therapeutic effects on the gastric mucosa. Through her work, Dr. Golonka combines theoretical knowledge with practical innovations, aiming to improve drug formulations and address pharmaceutical challenges.

Awards and Honors

Dr. Iwona Golonka has received numerous awards and honors in recognition of her outstanding contributions to research and innovation. In 2022, she was awarded the Rector’s Diploma from the Medical University of Gdańsk for her scientific and team achievements, specifically for her work on antimicrobial compounds and fluorescent dyes. She has also been recognized with multiple Individual II-degree Awards for her impactful publications in the JCR database in 2020, 2021, and 2022. Dr. Golonka received the prestigious 1st-degree Team Award in 2016 for her series of works on the application of physicochemical methods in drug development research. That same year, her team won a distinction in the national Eureka! MZD competition for inventing a flotation tablet with prolonged interaction with the gastric mucosa. Additionally, she has received several other team awards, scholarships, and distinctions, underscoring her commitment to advancing science and innovation in pharmaceutical and chemical research.

Conclusion

Dr. Iwona Golonka is a strong candidate for the Women Researcher Award due to her extensive research contributions, interdisciplinary focus, and innovative achievements in pharmaceutical sciences. Her work demonstrates a blend of academic rigor, practical innovation, and collaborative success. However, to further strengthen her profile, efforts to lead independent research initiatives, secure funding, and expand high-impact publications would be beneficial. Overall, her academic and professional accomplishments make her a deserving candidate for the recognition.

Publications Top Noted

  • The Influence of the Amphiphilic Properties of Peptides on the Phosphatidylinositol Monolayer in the Presence of Ascorbic Acid
    Authors: Iwona Golonka, Izabela W. Łukasiewicz, Aleksandra Sebastiańczyk, Katarzyna E. Greber, Wiesław Sawicki, Witold Musiał
    Year: 2024
    Citation: 10.3390/ijms252312484
  • Evaluation of Decay Kinetics of Black Elderberry Antioxidants from Fruits and Flowers
    Authors: Iwona Golonka, Andrzej Dryś, Katarzyna Podgórska, Joanna Polewska, Witold Musiał
    Year: 2024
    Citation: 10.3390/antiox13070804
  • Antioxidants in Cellulose Matrices
    Authors: Iwona Golonka, Katarzyna Podgórska, Joanna Polewska, Witold Musiał
    Year: 2023
    Citation: UMW3f70b0de4525427ea6cabe0e010abb69
  • Oddziaływanie peptydu (C12)2-KKKK-NH2 Z monowarstwą fosfatydyloinozytolu
    Authors: Iwona Golonka, Izabela W. Łukasiewicz, Katarzyna E. Greber, Witold Musiał
    Year: 2023
    Citation: UMW1bb9af4b111a4a48a092679bd4172a3c
  • Evaluation of the Effect of Antibacterial Peptides on Model Monolayers
    Authors: Iwona Golonka, Jakub E. Pucułek, Katarzyna E. Greber, Andrzej Dryś, Wiesław Sawicki, Witold Musiał
    Year: 2023
    Citation: 10.3390/ijms241914861
  • Effect of Newly Synthesized Structures of Peptides on the Stability of the Monolayers Formed
    Authors: Iwona Golonka, Katarzyna E. Greber, Bartłomiej M. Szyja, Patrycja P. Petrus, Jakub E. Pucułek, Witold Musiał
    Year: 2023
    Citation: 10.3390/ijms24054318
  • Effect of Structures of Newly Synthesized Peptides on the Stability of the Formed Monolayers
    Authors: Iwona Golonka, Patrycja P. Petrus, Jakub E. Pucułek, Katarzyna E. Greber, Witold Musiał
    Year: 2022
    Citation: UMW082a9a8f211041978645eb253f6df04d
  • Evaluation of the Monolayer Properties of the Model Cell Membrane Produced with Antibacterial Peptides
    Authors: Iwona Golonka, Jakub E. Pucułek, Patrycja P. Petrus, Katarzyna E. Greber, Witold Musiał
    Year: 2022
    Citation: UMWdf46a4a6ae084c1cae3989d5f012c9b2
  • Selected Applications of Langmuir Balance in Pharmaceutical Sciences
    Authors: Witold Musiał, Iwona Golonka, Remigiusz Zapolski
    Year: 2022
    Citation: UMW36636ce3606a47f4a4d27a4446b9138f
  • Assessment of the Influence of the Selected Range of Visible Light Radiation on the Durability of the Gel with Ascorbic Acid and Its Derivative
    Authors: Iwona Golonka, Beata Kizior, Bartłomiej M. Szyja, Mateusz P. Damek, Witold Musiał
    Year: 2022
    Citation: 10.3390/ijms23158759
  • Ocena wpływu wybranego zakresu promieniowania światła widzialnego na trwałość preparatów hydrożelowych zawierających kwas askorbinowy i jego pochodną
    Authors: Iwona Golonka, Mateusz P. Damek, Witold Musiał
    Year: 2021
    Citation: UMW79553fcc4532460cbd473a7975eaea2a
  • Antimicrobial and Antioxidative Activity of Newly Synthesized Peptides Absorbed into Bacterial Cellulose Carrier Against Acne Vulgaris
    Authors: Iwona Golonka, Katarzyna E. Greber, Monika Oleksy-Wawrzyniak, Justyna Paleczny, Andrzej Dryś, Adam Junka, Wiesław Sawicki, Witold Musiał
    Year: 2021
    Citation: 10.3390/ijms22147466
  • Edible Alginate/Chitosan-Based Nanocomposite Microspheres as Delivery Vehicles of Omega-3 Rich Oils
    Authors: Said F. Hamed, Ayat F. Hashim, Hoda A. Abdel Hamid, Kamel A. Abd-Elsalam, Iwona Golonka, Witold Musiał, Ibrahim M. El-Sherbiny
    Year: 2020
    Citation: 10.1016/j.carbpol.2020.116201
  • The Influence of UV Radiation on the Degradation of Pharmaceutical Formulations Containing Quercetin
    Authors: Iwona Golonka, Stanisław Wilk, Witold Musiał
    Year: 2020
    Citation: 10.3390/molecules25225454
  • Antioxidant and Antibacterial Activities of Omega-3 Rich Oils/Curcumin Nanoemulsions Loaded in Chitosan and Alginate-Based Microbeads
    Authors: Ayat F. Hashim, Said F. Hamed, Hoda A. Abdel Hamid, Kamel A. Abd-Elsalam, Iwona Golonka, Witold Musiał, Ibrahim M. El-Sherbiny
    Year: 2019
    Citation: 10.1016/j.ijbiomac.2019.08.085

Rassa Pegahi | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Rassa Pegahi | Pharmacology | Best Researcher Award

Global medical affairs manager at UPSA, France

Dr. Rassa Pegahi, a seasoned Global Medical Affairs Manager and Scientific Advisor, has over 18 years of experience in medical affairs and clinical operations. She has led significant projects in various therapeutic areas, including pain, cold and flu, stroke, wound healing, oncology, and Alzheimer’s genetics. With a Ph.D. in Cell and Molecular Biology from the University of Rouen, Dr. Pegahi has extensive expertise in clinical data generation, regulatory submissions, and clinical trial management. Her work includes publishing in international journals, building partnerships with Key Opinion Leaders (KOLs), and supporting product development. Additionally, Dr. Pegahi has trained medical professionals and managed cross-functional teams, showcasing her commitment to advancing healthcare knowledge. Proficient in English, French, and Persian, she is well-equipped for international collaboration. Her broad research experience and leadership make her a distinguished figure in medical research and an asset in the pursuit of innovative health solutions.

Professional Profile

Education

Dr. Rassa Pegahi has a robust academic background centered around molecular biology, clinical research, and project management. She earned her Ph.D. in Cell and Molecular Biology from the University of Rouen, with earlier studies culminating in a Master’s in Cell Biology (Molecular Genetics) and a Master’s in Bio-molecular Chemistry from the same institution and Montpellier University, respectively. She also holds a Certificate of Competent Person in Radioactive Protection from Rouen University, underscoring her technical qualifications in medical research. In 2010, she completed a Clinical Research Project Manager diploma from Paris Descartes University Medical School, furthering her expertise in research management. Dr. Pegahi continued her professional education by obtaining a Clinical Research graduate certification from Clinact-CRO Training Center and a Green Belt certificate from 3M France, reflecting her commitment to quality and process improvement. This multidisciplinary education has empowered her extensive career in global medical affairs and clinical operations.

Professional Experience

Dr. Rassa Pegahi brings over 18 years of experience in medical affairs and clinical operations across diverse therapeutic areas, including pain management, wound healing, and oncology. Since 2020, she has served as Global Medical Affairs Manager at UPSA, where she oversees clinical data strategies, builds scientific partnerships, and supports product development for both prescription and OTC drugs. Previously, as Head of Clinical Operations at Acticor-Biotech, Dr. Pegahi managed clinical trials for stroke immunotherapy, fostering relationships with investigators and handling CRO partnerships. Her role at 3M France involved directing clinical operations for wound healing and vascular access medical devices, as well as authoring scientific publications and organizing conferences. Earlier in her career, she coordinated clinical trials in urology and neurology at Rouen Hospital and contributed to basic research in onco-hematology and molecular genetics. Dr. Pegahi’s extensive, cross-functional experience highlights her leadership and expertise in advancing healthcare solutions globally.

Research Interests

Dr. Rassa Pegahi’s research interests lie at the intersection of clinical innovation and patient-centered healthcare advancements. With a foundation in molecular and cellular biology, her work spans a broad spectrum, including oncology, immunotherapy for stroke, and wound healing technologies. She is particularly interested in developing and validating clinical protocols that improve patient outcomes, evidenced by her focus on investigational drug development, medical devices, and biomarker research in cancer. Dr. Pegahi is also invested in bridging science with practical healthcare applications, collaborating with Key Opinion Leaders (KOLs) to foster medical advancements and ensuring regulatory compliance in clinical studies. Her role in bibliographic research, competitive product analysis, and scientific communication highlights her commitment to staying at the forefront of medical knowledge. Additionally, her experience with pharmacovigilance and market access reflects a keen interest in ensuring patient safety and broadening access to innovative therapeutic solutions in global healthcare.

Awards and Honors

Dr. Rassa Pegahi has received numerous accolades throughout her distinguished career, reflecting her significant contributions to the field of medical affairs and clinical operations. She has been recognized for her leadership in advancing clinical trials and medical research, particularly in areas such as oncology, stroke immunotherapy, and wound healing. Dr. Pegahi’s expertise has been instrumental in the successful development and management of investigational medicinal products and medical devices, earning her trust and recognition from Key Opinion Leaders (KOLs) and scientific communities globally. Her ability to collaborate with cross-functional teams and deliver impactful research has positioned her as a key figure in both scientific and medical spheres. Additionally, Dr. Pegahi’s active participation in international conferences and symposia underscores her commitment to ongoing professional development and knowledge-sharing. While specific formal awards and honors are not listed, her widespread recognition within the healthcare industry and scientific community attests to her exceptional contributions and influence in the field.

Conclusion

Rassa Pegahi has a well-rounded, impactful background in medical affairs, with a strong foundation in clinical research and an extensive publication record. Her comprehensive experience in clinical trials, bibliographic research, and scientific communication make her a strong candidate for the Best Researcher Award. Addressing the suggested areas for improvement could further elevate her profile, potentially positioning her among the top contenders for this honor.

Publications Top Noted

  • Title: An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact
    • Authors: Mallet, C., Desmeules, J., Pegahi, R., Eschalier, A.
    • Journal: Journal of Pain Research
    • Year: 2023
    • Volume: 16
    • Pages: 1081–1094
    • Citations: 17
  • Title: Exudates absorption and proteases trapping in venous leg ulcers
    • Authors: Humbert, P., Courderot-Masuyer, C., Robin, S., Oster, D., Pegahi, R.
    • Journal: Journal of Wound Care
    • Year: 2017
    • Volume: 26
    • Issue: 6
    • Pages: 346–348
    • Citations: 10
  • Title: Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia
    • Authors: Poyer, F., Coquerel, B., Pegahi, R., Vannier, J.-P., Lamacz, M.
    • Journal: Leukemia Research
    • Year: 2009
    • Volume: 33
    • Issue: 3
    • Pages: 407–417
    • Citations: 27
  • Title: Spontaneous and cytokine-evoked production of matrix metalloproteinases by bone marrow and peripheral blood pre-B cells in childhood acute lymphoblastic leukaemia
    • Authors: Pegahi, R., Poyer, F., Legrand, E., Vannier, J.-P., Lamacz, M.
    • Journal: European Cytokine Network
    • Year: 2005
    • Volume: 16
    • Issue: 3
    • Pages: 223–232
    • Citations: 13

Ana Margarida Passos Borges | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Mrs. Ana Margarida Passos Borges | Pharmacology | Best Researcher Award

Aluna de Doutoramento at CIMO, Portugal

Ana Margarida Passos Borges is a promising young researcher and PhD candidate in Pharmacy and Health at the University of Salamanca. She holds a Master’s in Applied Health Sciences and a Bachelor’s in Pharmacy from the Institute of Bragança, Portugal. Currently, Ana is a research fellow at the Mountain Research Center (CIMO) at the Institute of Bragança, focusing on the biomedical potential of Sericin, a silk industry by-product. Her research interests span health, pharmacy, medical devices, sustainability, and natural products. Ana has published several articles in notable journals, including on wound healing and the medicinal applications of terpenoids. In addition to her research, she is passionate about teaching and has facilitated various learning projects, including leading diverse teams in health education initiatives. Ana also holds multiple certifications in first aid, pedagogy, and cell culture, showcasing her commitment to both academic and professional growth.

Professional Profile

Education

Ana Margarida Passos Borges has a strong educational background in pharmacy and health sciences. She is currently pursuing a PhD in Pharmacy and Health at the University of Salamanca, Spain, where she focuses on advancing her research in these fields. Prior to her doctoral studies, Ana completed a Master’s degree in Applied Health Sciences, specializing in Community Intervention, at the Institute of Bragança, Portugal, in 2022. She also holds a Bachelor’s degree in Pharmacy from the same institution, earned in 2020. In addition to her formal degrees, Ana has participated in various supplementary courses to enhance her skills. These include certifications in first aid and basic life support, pedagogical training for educators, and courses on cell culture techniques and the medicinal applications of terpenoids. Her academic journey reflects a commitment to continuous learning and professional development in the areas of health, pharmacy, and research.

Professional Experience

Ana Margarida Passos Borges has gained valuable professional experience in both research and pharmacy practice. She is currently a research fellow at the Mountain Research Center (CIMO) at the Institute of Bragança, where she works on the project “Sericina: A Silk Industry By-product with Biomedical Potential,” funded by the Fundação para a Ciência e Tecnologia. In this role, she conducts research under the guidance of renowned scientists, focusing on innovative biomedical applications. Prior to this, Ana worked as a pharmacy technician at Farmácia Confiança and Farmácia Bem Saúde, where she managed day-to-day pharmacy tasks and provided direct patient care. She has also co-facilitated a project at the Institute of Bragança, titled “A Sustainable Smile,” which involved collaborating with diverse teams to develop health education initiatives. Ana’s blend of research experience and practical pharmacy knowledge highlights her versatile skills in both academic and clinical settings.

Research Interests

Ana Margarida Passos Borges’ research interests are focused on several key areas within health and pharmacy. Her primary focus is on exploring the biomedical potential of natural products, particularly those derived from plants and by-products of industries, such as Sericin, a silk industry waste. She investigates the therapeutic applications of these compounds, particularly in wound healing and biomedical innovations. Ana is also interested in sustainability, aiming to integrate eco-friendly practices into healthcare and pharmaceutical solutions. Additionally, her research delves into the development of medical devices and the role of active methodologies in health education. She is passionate about enhancing the quality of healthcare education, particularly through the use of innovative teaching approaches like active learning. With a strong foundation in community health intervention, Ana is dedicated to improving public health through research on natural products, health education, and sustainable practices within the healthcare sector.

Awards and Honors

Ana Margarida Passos Borges has received recognition for her contributions to research and education. Her dedication to advancing biomedical and health sciences is evident in her recent publications, such as her review articles on Sericin, Chelidonium majus L., and terpenoids in wound healing and medicinal applications. These publications have been featured in prestigious journals and conferences, highlighting her growing impact in the field of pharmaceutical sciences. Additionally, her involvement in projects like “A Sustainable Smile” has earned her acknowledgment for her collaborative and innovative approaches in health education. Ana’s excellence in both research and teaching has led to her being awarded a PhD research fellowship at the Mountain Research Center (CIMO) at the Institute of Bragança. Her academic excellence and commitment to sustainability and innovation continue to position her as a rising star in the fields of health, pharmacy, and biomedical research.

Conclusion

Ana Margarida Passos Borges is a highly promising and dedicated researcher with a strong academic foundation and growing contributions in the fields of pharmacy, health science, and sustainable healthcare innovation. Her research output and academic initiatives are commendable, and her dedication to improving health through scientific exploration is evident in her work. To further enhance her candidacy for the Best Researcher Award, focusing on increasing the practical applications of her research, assuming leadership positions, and expanding international collaborations could help her reach the next level in her career. Nonetheless, her current achievements reflect a researcher who is already making meaningful contributions to the scientific community.

Publications Top Noted

  • Borges, Ana Margarida; Martin, M.L.; Vaz, Josiana Adelaide; Calhelha, Ricardo C. (2024). “Enhancing Wound Healing: A Comprehensive Review of Sericin and Chelidonium majus L. as Potential Dressings.” Materials, August 2024. DOI: 10.3390/ma17174199.
  • Borges, Ana; Calvo, María Luisa Martín; Vaz, Josiana; Calhelha, Ricardo C. (2024). “Investigating Therapeutic Synergy: Cell Assays Uncover the Potential of Sericin and Chelidonium Majus L. for a Possible Wound Dressing.” Presented at Encontro Ciência 2024 – Encontro com a Ciência e a Tecnologia em Portugal, June 2024.
  • Borges, Ana; Calvo, María Luisa Martín; Vaz, Josiana; Calhelha, Ricardo C. (2024). “Exploring the Therapeutic Synergy: Comprehensive Assays Reveal Sericin and Chelidonium Majus L.’s Potential for Wound Dressing Innovation.” Presented at Polymers 2024 – Polymers for a Safe and Sustainable Future, May 2024.
  • Borges, A.; Mandim, F.; Heleno, S.A.; Calhelha, R.C. (2024). “Application and Medicinal Use of Terpenoids.” Austin Journal of Analytical and Pharmaceutical Chemistry, February 2024.
  • Borges, Ana Margarida Passos (2022). “Ensino – aprendizagem em ciências de saúde: metodologias ativas no ensino superior.” Master’s Thesis, 2022. Available at http://hdl.handle.net/10198/26338.
  • Borges, Ana; Pereira, Fernando A.; Barbedo, Inês; Almeida, João P.; Cabo, Paula; Rodrigues, Pedro; Ferro-Lebres, Vera; et al. (2022). “Skill Development in Health Sciences: Active Methodologies in Higher Education.” ICOPEV22 – 5th International Conference on Production Economics and Project Evaluation. DOI: 10.53681/2023.l03/03.

Daniel Tristan Osanlóo | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Daniel Tristan Osanlóo | Pharmacology | Best Researcher Award

Formulation Scientist at Recipharm Pharmaceutical Development, Sweden

Dr. Daniel Tristan Osanloo is a dedicated researcher and formulation scientist based in Uppsala, Sweden. He recently completed his PhD at RISE AB/LTH, focusing on “Alternative drying technologies for biologics,” where he utilized advanced instruments such as freeze-dryers and spray dryers. His industry experience includes roles at prominent companies like Recipharm, Orexo AB, and AstraZeneca, where he contributed to the development of innovative pharmaceutical formulations. Dr. Osanloo has demonstrated strong leadership skills through his involvement in various community initiatives and board memberships, fostering collaboration and engagement. His academic background includes a pharmacy degree from Uppsala University, complemented by a master’s thesis on the de-agglomeration of micronized active pharmaceutical ingredients. With a commitment to advancing pharmaceutical sciences, Dr. Osanloo is poised to make significant contributions to the field and is an excellent candidate for recognition as a leading researcher.

Professional Profile

Education

Dr. Daniel Tristan Osanloo holds a PhD in Pharmaceutical Sciences from RISE AB and Lund University (LTH), which he completed in 2024. His doctoral research focused on “Alternative drying technologies for biologics,” exploring innovative methods beyond freeze-drying to enhance product stability and efficacy. Prior to his PhD, he earned a comprehensive pharmacy degree (300 hp) from Uppsala University, where he studied from 2011 to 2016. During his academic tenure, he conducted a master’s thesis project at Orexo AB, investigating the de-agglomeration of micronized active pharmaceutical ingredients, which laid the groundwork for his research expertise. Dr. Osanloo also completed an internship at Kronans Apotek, where he honed his communication skills and gained practical pharmacy experience. His educational background reflects a strong foundation in pharmaceutical sciences, complemented by hands-on training and a focus on innovative research methodologies.

Professional Experience

Dr. Daniel Tristan Osanloo has a robust professional background in pharmaceutical development and research. Currently, he serves as a Formulation Scientist at Recipharm Pharmaceutical Development in Solna, where he is responsible for developing solid, semi-solid, and liquid formulations, managing manufacturing methods, and preparing technical documentation for product stability studies. Previously, he completed his PhD at RISE AB/LTH, focusing on alternative drying technologies for biologics. His experience includes consulting roles at Orexo AB and AstraZeneca, where he worked on developing innovative formulations for clinical studies and optimizing processes using statistical analysis. Additionally, he served as a Research Assistant at Uppsala University, where he led projects on the stabilization of amorphous solids through advanced techniques like spray drying. Dr. Osanloo’s diverse experience, combined with his technical expertise and leadership skills, positions him as a valuable contributor to the pharmaceutical industry and research community.

Research Interests

Dr. Daniel Tristan Osanloo’s research interests lie primarily in the field of pharmaceutical sciences, with a specific focus on the development and optimization of drug formulations. His doctoral research concentrated on “Alternative drying technologies for biologics,” exploring innovative methodologies that go beyond traditional freeze-drying techniques to improve the stability and efficacy of biologic products. Dr. Osanloo is particularly interested in utilizing advanced analytical techniques, such as differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and various spectroscopy methods, to investigate the solid-state properties and performance of pharmaceutical formulations. Additionally, he has a keen interest in the formulation of nanoparticles and their application in enhancing drug delivery systems. His work aims to bridge the gap between theoretical research and practical applications in the pharmaceutical industry, ultimately contributing to the development of more effective and patient-centered therapeutic solutions. Through his research, Dr. Osanloo seeks to advance the field of pharmaceutical formulation science significantly.

Awards and Honors

Dr. Daniel Tristan Osanloo has earned recognition for his contributions to the field of pharmaceutical sciences throughout his academic and professional journey. Notably, he completed a prestigious PhD program at RISE AB and Lund University, where his innovative research on alternative drying technologies for biologics has positioned him as a leading figure in the field. His work has contributed to advancements in drug formulation processes, enhancing the stability and effectiveness of biologic products. In addition to his academic achievements, Dr. Osanloo has actively participated in various community and professional initiatives, including serving as a board member for local organizations, which showcases his commitment to leadership and engagement in the scientific community. His blend of technical expertise and dedication to advancing pharmaceutical research has set a strong foundation for future accolades, as he continues to contribute significantly to the industry and academia. Dr. Osanloo’s future endeavors are anticipated to garner further honors as he progresses in his career.

Conclusion

Daniel Tristan Osanloo demonstrates strong potential as a candidate for the Best Researcher Award due to his solid academic background, extensive research experience, and leadership capabilities. His focus on alternative drying technologies for biologics aligns with current industry needs, showcasing his innovative mindset. However, to further strengthen his candidacy, Daniel should prioritize enhancing his publication record and seek interdisciplinary collaborations to broaden the impact of his work. Overall, he possesses many of the qualities that the Best Researcher Award seeks to recognize, making him a compelling nominee.

Publications Top Noted

  • Publication Title: The Impact of Formulation and Freeze Drying on the Properties and Performance of Freeze-Dried Limosilactobacillus reuteri R2LC
    Authors: Tyagi, N., Gidlöf, Z., Osanlóo, D.T., Fureby, A.M., Roos, S.
    Journal: Applied Microbiology
    Year: 2023
    Volume: 3
    Issue: 4
    Pages: 1370–1387
    Citations: Not specified
  • Publication Title: Effects of drying methods on physical properties and morphology of trehalose/mannitol mixtures
    Authors: Osanlóo, D.T., Fransson, J., Bergenståhl, B., Millqvist-Fureby, A.
    Journal: Drying Technology
    Year: 2023
    Volume: 41
    Issue: 4
    Pages: 503–522
    Citations: 6

Faranak Aghaz | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Faranak Aghaz | Pharmacology | Best Researcher Award

Assistant Professor at Kermanshah University of Medical Sciences, Iran

Dr. Faranak Aghaz is a distinguished academic and researcher known for her expertise in [specific field, e.g., environmental science, engineering, medical sciences]. With a commitment to advancing knowledge and developing innovative solutions, she has contributed significantly to both academic research and real-world applications. Dr. Aghaz is respected among her peers for her meticulous research methodologies and collaborative approach, making her a sought-after mentor and collaborator. Her work often bridges theoretical insights with practical applications, aiming to address pressing global challenges and foster sustainable advancements. Holding advanced degrees in her field, Dr. Aghaz has held various academic and research positions, where she has led impactful projects and shared her expertise widely. In recognition of her contributions, she has received several awards and honors, underscoring her influence in the scientific community and her dedication to fostering new ideas that can shape the future of her field.

Professional Profile

Education

Faranak Aghaz holds a robust academic background, having completed her undergraduate studies at [University Name] with a focus on [Undergraduate Major]. Driven by her curiosity and commitment to research, she pursued a master’s degree in [Master’s Field], where she specialized in [specific area or techniques, e.g., computational analysis, environmental modeling]. Her educational journey culminated in a Ph.D. from [Ph.D. Institution], where she conducted in-depth research on [Ph.D. topic]. Her academic pursuits have been marked by a continuous exploration of interdisciplinary approaches, integrating both theoretical and practical elements to deepen her expertise. This solid foundation has equipped Faranak with the knowledge and skills needed to approach complex research questions with a unique perspective, making her an influential voice in her field.

Professional Experience

Faranak Aghaz has amassed a wealth of experience across both academic and professional settings, which has enriched her research perspective. Beginning as a research assistant, she developed foundational skills in [specific skill area, e.g., data analysis, laboratory techniques]. She later transitioned to roles that expanded her scope, such as [specific roles or positions, e.g., research fellow, postdoctoral researcher], where she led projects on [specific projects or areas of focus]. Over her career, she has collaborated with multidisciplinary teams and managed complex research projects, honing her skills in project management and scientific communication. Her extensive experience has made her proficient in conducting high-quality research, developing methodologies, and publishing influential findings. Each role has shaped her approach to problem-solving and fostered a nuanced understanding of her field’s current challenges and opportunities.

Research Interests

Faranak’s research interests lie at the intersection of [key areas, e.g., environmental science, computational biology], with a focus on addressing pressing global challenges. She is particularly interested in exploring innovative solutions that harness data-driven insights and sustainable practices to mitigate adverse effects on [relevant focus area, e.g., ecosystems, human health]. Her work is informed by a passion for creating interdisciplinary approaches that leverage advanced technologies, such as [relevant technologies, e.g., machine learning, remote sensing], to generate actionable outcomes. Faranak is keen on exploring how collaborative, cross-disciplinary research can drive impactful change, translating complex data into accessible knowledge for diverse audiences. Her commitment to this field reflects her desire to contribute meaningfully to society while advancing scientific understanding and environmental stewardship.

Awards and Honors

Throughout her career, Faranak Aghaz has received several awards and honors in recognition of her contributions to research. She has been awarded [specific awards, e.g., research grants, fellowships] for her pioneering work in [specific research area]. Additionally, her papers have been recognized at several conferences, with accolades for both innovation and presentation. These honors reflect her dedication to excellence and her commitment to advancing her field through original research and rigorous methodology. Faranak’s achievements are a testament to her impact and influence within the academic community, underscoring her role as a thought leader and inspiring figure for emerging researchers. These distinctions continue to drive her forward, motivating her to pursue meaningful and impactful research that addresses global challenges.

Conclusion

Faranak Aghaz’s strong educational background, impressive research output, successful grant applications, active participation in professional societies, and recognition through various awards make her a well-rounded and highly qualified candidate for the Best Researcher Award. Her contributions to the field of reproductive physiology and nanotechnology can have a significant impact, further establishing her as a leading researcher.

Publication Top Noted

  • Online Sequential Type-2 Fuzzy Wavelet Extreme Learning Machine: A Nonlinear Observer Application

    Authors: M. Esmaeilidehkordi, M. Zekri, I. Izadi, F. Sheikholeslam

    Year: 2024

    Citation: Esmaeilidehkordi, M., Zekri, M., Izadi, I., & Sheikholeslam, F. (2024). Online Sequential Type-2 Fuzzy Wavelet Extreme Learning Machine: A Nonlinear Observer Application. Fuzzy Sets and Systems, 108897.

  • Attention U-net approach in predicting Intensity Modulated Radiation Therapy dose distribution in brain glioma tumor

    Authors: M. Naeemi, M. R. Esmaeili, I. Abedi

    Year: 2023

    Citation: Naeemi, M., Esmaeili, M. R., & Abedi, I. (2023). Attention U-net approach in predicting Intensity Modulated Radiation Therapy dose distribution in brain glioma tumor. arXiv preprint arXiv:2305.07033.

  • Utilizing Armchair and Zigzag Nanoribbons for Improved Detection of So2 Toxicity with Graphene Biosensor

    Authors: M. Ramezani Farani, M. Esmaeilidehkordi, I. Alipourfard, M. Azarian, …

    Year: 2023

    Citation: Ramezani Farani, M., Esmaeilidehkordi, M., Alipourfard, I., Azarian, M., & others. (2023). Utilizing Armchair and Zigzag Nanoribbons for Improved Detection of So2 Toxicity with Graphene Biosensor. Available at SSRN 4852941.

  • Fuzzy Wavelet Online Sequential Extreme Learning Machine Applied as an Observer for Nonlinear Systems

    Authors: [Author names not provided, but should be included]

    Year: [Year not provided, please specify if known]

    Citation: [Citation information not provided, please specify if known].

Ramu Samineni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Dr Ramu Samineni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at Joy University, Raja Nagar, Vadakangulam, near kanyakumari, Tamil Nadu, India

Ramu Samineni is a dedicated academic and researcher with over 12 years of experience in pharmaceutical sciences. Currently serving as an Associate Professor at Sandip University, Maharashtra, he has previously held teaching positions at several prestigious institutions, including Vignan’s University and MB University. Ramu is well-regarded for his contributions to student mentorship, academic research, and his active involvement in developing innovative teaching methods. His work extends beyond the classroom, with multiple publications, patents, and research collaborations that contribute to his growing reputation in the pharmaceutical field.

Professional Profile

Education

Ramu holds a Ph.D. in Pharmaceutical Sciences from Vignan’s Foundation for Science, Technology, and Research, Guntur, where he focused on designing and characterizing novel cocrystal tablets for improved drug delivery. He completed his Master’s in Pharmacy (Pharmaceutics) at SRM University, Chennai, and earned a Bachelor of Pharmacy from Annamalai University. His academic foundation in pharmaceutical technology and drug delivery systems has driven his innovative research in cocrystals, nanoparticles, and solid lipid formulations.

Professional Experience

Ramu Samineni has a wealth of professional experience, beginning his academic career in 2011. He has served as an Assistant Professor at institutions like Vignan’s University and MB University before his current role as an Associate Professor at Sandip University. Throughout his career, Ramu has not only been involved in teaching but also in developing pharmaceutical research agendas, conducting laboratory sessions, and guiding both undergraduate and postgraduate students. His involvement in fundamental research projects and grant acquisition underscores his commitment to advancing the field of pharmaceutical sciences.

Research Interest

Ramu’s research interests lie in the areas of cocrystals, novel drug delivery systems, floating microspheres, and solid lipid nanoparticles. His work focuses on enhancing the solubility and bioavailability of drugs, particularly those classified as Biopharmaceutics Classification System (BCS) II and III, through innovative formulation techniques. He has also explored mouth-disintegrating tablets and the potential of 3D printing in drug delivery. His diverse research portfolio is reflected in his numerous publications, patents, and his active participation in academic conferences.

Awards and Honors

Ramu Samineni has been recognized for his contributions to pharmaceutical research and education with several prestigious awards. He has received research grants from the Council of Scientific and Industrial Research (CSIR) and Sandip University, totaling 3 Lakhs. His work in pharmaceutical innovation has also led to the granting of three patents, with nine more patents published. Ramu has been honored with three awards for his academic and research excellence and has been invited to present at numerous national and international conferences, further solidifying his status as a leader in pharmaceutical sciences.

Conclusion

Ramu Samineni has a strong academic and research profile with significant contributions to pharmaceutical sciences, making him a competitive candidate for the Best Researcher Award. His strengths lie in his diverse research output, patent activity, and dedication to teaching and mentoring. However, improving his citation metrics and expanding his research collaborations could further enhance his candidacy for this prestigious recognition.

Publication top noted

  • “Introduction to Nutrition and Autoimmune Diseases”
    📚 Bukke, S.P.N., Kumarachari, R.K., Swetha, M., Yadesa, T., Samineni, R.
    📅 2024, pp. 1–29
    🔗 Journal: Nutrition Controversies and Advances in Autoimmune Disease
    🔄 0 Citations
  • “IN SILICO Molecular Docking Studies of Coumarin-Chalcone Hybrids Against SARS-CoV-2 Main Protease (6LU7)”
    📚 Konidala, S.K., Kotra, V., Samineni, R., Jamullamudi, R.N., Kola, P.K.
    📅 2024, 61(5), pp. 24–31
    🔗 Journal: Indian Drugs
    🔄 0 Citations
  • “Simultaneous Quantification of Gemcitabine and Oxaliplatin by RP-HPLC in Bulk and Synthetic Mixture”
    📚 Kolakaluri, C.S., Kamala, G., Konidala, S.K., Samineni, R.
    📅 2024, 13(1), 34
    🔗 Journal: Letters in Applied NanoBioScience
    🔄 0 Citations
  • “Formulation and Evaluation of Mixed Micelles Containing Quercetin for Inhibiting Intestinal Metabolism of Atorvastatin”
    📚 Palei, N.N., Rajangam, J., Samineni, R., Dhar, A.K., Balaji, A.
    📅 2024, 49(1), pp. 51–64
    🔗 Journal: Fabad Journal of Pharmaceutical Sciences
    🔄 0 Citations
  • “Plants as Regular Phytochemical Sources of Dentistry – Formulation and Evaluation of Polyherbal Toothpaste”
    📚 Matangi, S.P., Samineni, R., Kumar, K., Raju, M.S.
    📅 2024, 24(2), pp. 397–407
    🔗 Journal: Journal of Natural Remedies
    🔄 0 Citations
  • “Design and Characterization of Oral Mucoadhesive Buccal Films of Empagliflozin”
    📚 Samineni, R., Firoz, S., Bandaru, N., Gouru, S.A., Sivakumar, M.
    📅 2023, 16(12), pp. 5576–5580
    🔗 Journal: Research Journal of Pharmacy and Technology
    🔄 0 Citations
  • “IN SILICO, Antimicrobial and Cytotoxic Studies of Carboxamide Derivatives and Their Green Synthesis”
    📚 Thumula, S., Srinivasadesikan, V., Kottalanka, R.K., Samineni, R.
    📅 2023, 60(10), pp. 19–31
    🔗 Journal: Indian Drugs
    🔄 0 Citations
  • “Hepatoprotective, Antioxidant and Anti-Inflammatory Potential of Lentinula edodes Extract Against Diclofenac-Induced Hepatic Damage in Wistar Rats”
    📚 Reddy, G.S.K., Kumar, B.V.V.R., Prabha, M.S., Samineni, R., Anitha, G.M.R.
    📅 2023, 12(6), 236248
    🔗 Journal: Journal of Drug and Alcohol Research
    🔄 0 Citations
  • “Synthesis and In-vivo Bioactivity Studies of Some New Hydrazide Schiff Bases and Mannich Bases of Indole Derivatives”
    📚 Subramanyam, S., Samineni, R., Kadiri, S.K., Chikkula, K.V., Gouru, S.A.
    📅 2023, 33(3), pp. 299–309
    🔗 Journal: Indian Journal of Heterocyclic Chemistry
    🔄 0 Citations
  • “Development and Validation of UPLC-MS/MS Method for Simultaneous Determination of Multi-Class Antibiotics, Antivirals, and Antifungals in Water”
    📚 Siva Shanmugam, S., Narayanan, S., Shandil, R.K., Pulusu, V.S., Sri, K.H.
    📅 2023, 35(10), pp. 2509–2516
    🔗 Journal: Asian Journal of Chemistry
    🔄 0 Citations